Israel Innovation Authority to Invest Almost $4 Million in Bio-Convergence R&D Programs
Error: Contact form not found.
by CTech Staff

Participants at the DLD Tel Aviv Digital Conference, Israel’s largest international high-tech gathering, held at the Old Train Station complex in Tel Aviv on Sept. 6, 2017. Photo: Miriam Alster/Flash90.
CTech – The Israel Innovation Authority (IIA) will invest nearly $4 million in a new call for proposals in the field of bio-convergence. The IIA announced on Thursday that it is inviting researchers in academia, hospitals, and commercial companies to submit requests for R&D funding to develop programs commercializing academic know-how for medical innovation in bio-convergence, an approach that integrates biology with additional disciplines from engineering such as electronics, AI, physics, computer science, nanotechnology, material science, and advanced genetic engineering. The total budget for the project will be NIS 13.5 million (approximately $3.92 million).
“Given that bio-convergence is still a burgeoning technological field, most relevant expertise in the area remains concentrated in academic institutions,” said Aharon Aharon, CEO of the Israel Innovation Authority. “The Israel Innovation Authority’s call for proposals will help in developing R&D programs with the potential to contribute to the commercial application of this technology. This synthesis of academia and industry is part of an overall attempt to develop an innovative ecosystem that will be an engine of growth for Israeli industry.”
This is the IIA’s first call for proposals from academia and industry in the field of bio-convergence in 2020, with the Israeli government’s tech investment arm hoping this will pave the way for commercial deployment through two separate tracks.
In the first track, the proposal must relate to applied multidisciplinary research in medicine, joining a top researcher in the life sciences with at least one leading researcher in the field of engineering, computer sciences, math, or physics. In the second track, the proposal will be for commercialization of medical expertise, developed through multidisciplinary life sciences research integrating engineering, computer science, mathematics, or physics.
The proposals must be submitted by September 21, with the results to be finalized in December 2020.
Gal Gadot’s Genesis Prize Becomes $3 Million Donation to Help Israeli Trauma, Mental Health Care
Chicago Museum Returns Nazi-Looted Painting to Heirs of Dutch Jewish Owner
Irish PM Defends ‘Genocide’ Comments by Soccer Team Manager After Backlash From Israel
The United Nations and the Fantasies That Feed the War
Is ‘The Daily Wire’ Film About ISIS Attacking a College Controversial?
5 Times the New York Times Ran Anti-Israel Content — and Its PR Team Ran Cover
Palestinian Authority Attacks Israel for Arresting Terrorist Who Killed a Father Just for Being Jewish
Argentina Charges Eight Over 1994 AMIA Bombing in Long-Running Fight for Justice
UN Adviser Notorious for Anti-Israel Bias Calls for Ending Military Aid to Ukraine
Germany’s Political Extremes Surge: Left Wins Berlin as AfD Takes Eastern State





UN Adviser Notorious for Anti-Israel Bias Calls for Ending Military Aid to Ukraine
Argentina Charges Eight Over 1994 AMIA Bombing in Long-Running Fight for Justice
Germany’s Political Extremes Surge: Left Wins Berlin as AfD Takes Eastern State
The United Nations and the Fantasies That Feed the War
Palestinian Authority Attacks Israel for Arresting Terrorist Who Killed a Father Just for Being Jewish



